Evidence map›Paper›PMID 26002130›Full record

ReviewEuropean radiology2015

Breast MRI: EUSOBI recommendations for women's information.

Ritse M Mann, Corinne Balleyguier, Pascal A Baltzer, Ulrich Bick, Catherine Colin, Eleanor Cornford, Andrew Evans, Eva Fallenberg, Gabor Forrai, Michael H Fuchsjäger and 14 more

Registry-linked trialAbstract readReview
In one paragraph

Review in European radiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05812040 (Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge), which is not on this map. Cited by 222 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
222citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05812040 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge: A Prospective, Exploratory Diagnostic Study

TypeinterventionalSponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRan2023 to 2024Enrolled88ConditionsBreast Neoplasms, Nipple DischargeArmsMagnetic Resonance Ductography (MRD), and High-Resolution Magnetic Resonance Ductography (HR-MRD)
3 · Its place in the literature

Who cites it

222 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Guideline
  5. Trial
  6. Trial
  7. A multiparametric [European journal of nuclear medicine and molecular imaging · 2019
    Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. RADar Reflector LocalisatIOn-SCOUTAnnals of surgical oncology · 2026
    Observational
  16. Article
  17. PEM as an adjunct to MRI or CESM for characterizing non-mass enhancement: a retrospective two-arm diagnostic study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  18. Article
  19. Article
  20. Article

162 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Ritse M MannDepartment of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Corinne BalleyguierDepartment of Radiology, Gustave-Roussy Institute, Villejuif, France.
Pascal A BaltzerDepartment of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Vienna, Austria.
Ulrich BickClinic of Radiology, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Catherine ColinRadiology Unit, Hospices Civils de Lyon, Centre Hospitalo-Universitaire Lyon Sud, Pierre Bénite Cedex, France.
Eleanor CornfordNottingham Breast Institute, Nottingham University Hospitals, Nottingham, UK.
Andrew EvansDundee Cancer Centre, Clinical Research Centre, Ninewells Hospital and Medical School, Dundee, UK.
Eva FallenbergClinic of Radiology, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Gabor ForraiMHEK Teaching Hospital University Semmelweis, Budapest, Hungary.
Michael H FuchsjägerDepartment of Radiology, Medical University of Graz, Graz, Austria.
Fiona J GilbertDepartment of Radiology, University of Cambridge, School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Thomas H HelbichDepartment of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Vienna, Austria.
Sylvia H Heywang-KöbrunnerNational Reference Centre Mammography, Munich, Munich, Germany.
Julia Camps-HerreroDepartment of Radiology, Hospital de la Ribera, Alzira, Valencia, Spain.
Christiane K KuhlUniversity Hospital of Aachen, Rheinisch-Westfälische Technische Hochschule, Aachen, Germany.
Laura MartincichRadiology Unit, IRCCS-FPO, Candiolo, Turin, Italy.
Federica PediconiDepartment of Radiological, Oncological and Pathological Sciences, Sapienza University, Rome, Italy.
Pietro PanizzaDepartment of Radiology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Luis J PinaDepartment of Radiology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
Ruud M PijnappelDepartment of Imaging, University Medical Centre Utrecht, Utrecht, The Netherlands.
Katja Pinker-DomenigDepartment of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Vienna, Austria.
Per SkaaneDepartment of Radiology, Oslo University Hospital Ullevaal, University of Oslo, Oslo, Norway.
Francesco SardanelliDepartment of Biomedical Sciences for Health, Università degli Studi di Milano, Radiology Unit, IRCCS Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, Milan, Italy. francesco.sardanelli@unimi.it.
European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition

Funding

Cancer Research UK 16465
6 · The paper itself

Abstract

unlabelledThis paper summarizes information about breast MRI to be provided to women and referring physicians. After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination. The structured report including BI-RADS® categories and further actions after a breast MRI examination are discussed. Breast MRI is a very sensitive modality, significantly improving screening in high-risk women. It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management. However, it is not a perfect test, and occasionally breast cancers can be missed. Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered. Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives). These risks should be discussed with women before a breast MRI is requested/performed. Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented. Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided. The text was reviewed by Europa Donna-The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI. KEY POINTS: • Information on breast MRI concerns advantages/disadvantages and preparation to the examination • Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked • Before menopause, scheduling on day 7-14 of the cycle is preferred • During the examination, it is highly important that the patient keeps still • Availability of prior examinations improves accuracy of breast MRI interpretation.

Indexed as

Practice Guidelines as TopicBreastBreast NeoplasmsEuropeFemaleHumansMagnetic Resonance ImagingAccess to informationBreastBreast cancerMagnetic resonance imagingPatient advocacy

Identifiers

PMID26002130
PMCPMC4636525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.